All In Biotech

Drug Trial Radar · NCT00611130

Vigabatrin for Treatment of Cocaine Dependence

Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study

Last checked: Nov 19, 2026Latest source record: Apr 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 186 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

186

Actual

Start

Jan 2008

Primary completion

May 2009

Study completion Oct 2012

Sponsor

Lead sponsor
Catalyst Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Feb 8, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to demonstrate that a larger proportion of vigabatrin-treated subjects than placebo-treated subjects will be cocaine-free in the last 2 weeks of treatment.

Conditions

  • Cocaine Dependence

Interventions

  • vigabatrinDrug

    Tablets twice a day for 9 weeks

  • placeboDrug

    tablets twice daily for 9 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Subjects in Each Treatment Group Abstinent During the Last 2 Weeks of Treatment.Time frame: Week 13

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Addiction Treatment Clinic

    Little Rock, Arkansas

  • St. Luke's Hospital Addiction Pharmacology Research Laboratory

    San Francisco, California

  • Friends Research Institute

    Torrance, California

  • Operation PAR

    Largo, Florida

  • Segal Institute for Clinical Research

    North Miami, Florida

  • Johns Hopkins Bayview Medical Center Center for Chemical Dependence

    Baltimore, Maryland

  • Boston University School of Medicine

    Boston, Massachusetts

  • New York University Mental Health and Addictive Disorders Research Program

    New York, New York

  • Cincinnati Addiction Research Center (CinARC)

    Cincinnati, Ohio

  • Dayton Veterans Affairs Medical Center

    Dayton, Ohio

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.